Did you know that your version of Internet Explorer is out of date?
To get the best possible experience using our website we recommend downloading one of the browsers below.

Internet Explorer 10, Firefox, Chrome, or Safari.

All COVID-19 updates and resources can be found on the CF Canada website here.

Skip To Content
Volunteer Advocate

News

All media inquiries can be directed to mediarelations@cysticfibrosis.ca or by calling 1-800-378-2233.


Position on barriers to access to break-through CF drug Trikafta in Canada
September 22, 2020

Introduction: Cystic Fibrosis Canada and the cystic fibrosis community, including more than 50 cystic fibrosis clinicians, have been reaching out to Members of Parliament calling for change as part of our relentless efforts to get immediate access to the break-through cystic fibrosis drug Trikafta and avoid preventable deaths among the Canadian cystic fibrosis community.

Read More
OPEN LETTER to elected officials and policymakers in Canada’s drug review and reimbursement system from cystic fibrosis clinicians
September 17, 2020

An open letter from Canadian cystic fibrosis clinicians calling upon the government to take action for Trikafta now. 

Read More
Clinical Trials Network Now Covers More Than 60% of Canadian CF Population
September 4, 2020

TORONTO, September 4, 2020Cystic Fibrosis Canada is proud to announce the expansion of the Cystic Fibrosis Canada Accelerating Clinical Trials Network (CF CanACT) from six sites across Canada, to ten.

Read More
New Research Shows 15% Reduction in Cystic Fibrosis Deaths by 2030 If Trikafta is Made Available Now
August 24, 2020

TORONTO, August 24, 2020 - Cystic Fibrosis Canada is imploring the government to take action given new research published today that demonstrates that access to the cystic fibrosis (CF) drug Trikafta in 2021 would result in profound health improvements for people living with cystic fibrosis who take the drug. By 2030 Trikafta could reduce the number of people living with severe lung disease by 60% and reduce the number of deaths by 15%.

Read More
Cystic Fibrosis Canada Partners with Evolve Fitness
July 28, 2020

TORONTO (July 28, 2020) – Cystic Fibrosis Canada is pleased to announce its year-long virtual partnership with Nova Scotia-based fitness centre, Evolve Fitness. Members of the cystic fibrosis (CF) community who sign up for a $30(CAD) monthly membership for online fitness classes will see $10 (CAD) of their membership fees donated to Cystic Fibrosis Canada every month, for a year.

Read More
pan-Canadian Pharmaceutical Alliance agrees to negotiate for access to life-changing cystic fibrosis treatments
June 12, 2020

TORONTO (June 12, 2020) – Today, Canadians with cystic fibrosis are one step closer to gaining access to a suite of life-changing treatments for cystic fibrosis as the pan-Canadian Pharmaceutical Alliance (pCPA) and the drugs’ manufacturer, Vertex Pharmaceuticals, have agreed to begin negotiations.

Read More
Statement: Black Lives Matter
June 5, 2020

A message from the CEO

Racist violence targeted at members of the Black community reminds us that silence in the face of injustice is never an option. Cystic Fibrosis Canada stands with the Black community. We at Cystic Fibrosis Canada will not remain silent when it comes to racism. Black Lives Matter.

Read More
16th Annual Walk to Make Cystic Fibrosis History Transformed into a Virtual Experience
June 2, 2020

TORONTO (June 2, 2020)The Walk to Make Cystic Fibrosis History: Virtual Challenge has raised more than $1.8 million to help fund critical cystic fibrosis (CF) research and care, as well as advocacy for improved access to life-changing CF medications that are desperately needed.

Read More
Early Data Suggests Encouraging Health Outcomes for People with Cystic Fibrosis who Have Contracted COVID-19
April 30, 2020

TORONTO (April 30, 2020) Led by the Cystic Fibrosis Trust’s CF Registry, the collaborative study includes data for 40 people with CF who have tested positive for COVID-19 in 8 different countries.

Read More
Letter to Provincial Health Ministers and drug program managers
April 29, 2020

Dear Provincial Health Ministers and Drug Program Managers,

Due to COVID-19, Cystic Fibrosis Canada recently called upon government and Vertex to provide people with cystic fibrosis access to precision medicines known as CFTR modulators for humanitarian reasons.

Since that time, we are pleased to learn that Vertex has made an offer to the pan-Canadian Pharmaceutical Alliance (pCPA).  I urge you to start negotiations on that offer now...

Read More